Skip to main content

Table 1 Characteristics of included studies for meta-analysis, 2010–2015, Ethiopia

From: The effect of disclosure on adherence to antiretroviral therapy among adults living with HIV in Ethiopia: a systematic review and meta-analysis

Study # Author Publication year Region Sample size Good Adherence Definition Disclosure Outcomes Good adherence OR
Among disclose Among non-disclose  
1 Mitiku et al. [37] 2013 Harari 239 > 95% of prescribed ARV drugs for the past 7 days. Family or others 164/208 44/208 1.09
2 Mohammed et al. [38] 2015 Oromia 237 <  3 missed doses/day over study period Community 175/197 22/197 3.41
3 Ketema et al. [36] 2015 Amhara 422 0 missed dose during the 30-day period prior to filling out the self-report. Religious leaders and others 357/422 65/422 1.96
4 Alagaw et al. [33] 2013 SNNPR 357 > = 95% of prescribed drugs in past 7 days. No specifics regarding disclosure 281/312 31/312 2.59
5 Tsega et al. [18] 2015 Amhara 351 <  3 missed doses over the entire time of therapy (Range: >6mo to < 3 yr) Family 265/284 19/284 1.13
6 Gelan [35] 2010 SNNPR 277 Patients who reported an intake of 95% or more of the prescribed medication Partner, family, relatives, friends and community 86/182 96/182 1.85
7 Asmare et al. [34] 2014 Amhara 377 <  3 missed doses per month Family/Relatives 37/55 18/55 0.85
  1. Note: all studies were cross-sectional